Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
11.18
+0.24 (2.19%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Beta Bionics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22
Market Capitalization
483---
Enterprise Value
387---
Debt / Equity Ratio
0.100.100.070.32
Asset Turnover
0.500.500.17-
Inventory Turnover
4.014.01--
Quick Ratio
5.475.479.543.12
Current Ratio
6.296.299.773.21
Return on Equity (ROE)
-81.35%-81.35%-123.17%-
Return on Assets (ROA)
-21.78%-21.78%-30.79%-
Return on Capital (ROIC)
-38.72%-38.72%-56.04%-
Buyback Yield / Dilution
--20.01%-6.13%-
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q